Frappe ERPNext 15.87.0 before 15.121.4 and 16.x before 16.36.0 contains a missing authorization vulnerability in an Accounts module endpoint that changes Period Closing Voucher job status without permission checks and accepts a request method triggerable cross-site. Authenticated users without an Accounts role, or cross-site pages opened by authenticated users, can send requests naming a scheduled job to stop accounting jobs from completing.

Project Subscriptions

Vendors Products
Erpnext Subscribe
Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Sat, 21 Nov 2026 16:45:00 +0000

Type Values Removed Values Added
Description Frappe ERPNext 15.87.0 before 15.121.4 and 16.x before 16.36.0 contains a missing authorization vulnerability in an Accounts module endpoint that changes Period Closing Voucher job status without permission checks and accepts a request method triggerable cross-site. Authenticated users without an Accounts role, or cross-site pages opened by authenticated users, can send requests naming a scheduled job to stop accounting jobs from completing.
Title Frappe ERPNext 15.87.0 before 15.121.4 Missing Authorization in Period Closing Voucher Status
First Time appeared Frappe
Frappe erpnext
Weaknesses CWE-352
CPEs cpe:2.3:a:frappe:erpnext:*:*:*:*:*:*:*:*
Vendors & Products Frappe
Frappe erpnext
References
Metrics cvssV3_1

{'score': 4.3, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N'}

cvssV4_0

{'score': 5.3, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-11-21T16:33:42.972Z

Reserved: 2026-11-21T00:04:18.249Z

Link: CVE-2026-134398

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Deferred

Published: 2026-11-21T17:17:03.270

Modified: 2026-11-21T17:17:03.407

Link: CVE-2026-134398

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses